Biophysical Kv3 channel alterations dampen excitability of cortical PV interneurons and contribute to network hyperexcitability in early Alzheimer's

Abstract

In Alzheimer's disease (AD), a multitude of genetic risk factors and early biomarkers are known. Nevertheless, the causal factors responsible for initiating cognitive decline in AD remain controversial. Toxic plaques and tangles correlate with progressive neuropathology, yet disruptions in circuit activity emerge before their deposition in AD models and patients. Parvalbumin (PV) interneurons are potential candidates for dysregulating cortical excitability, as they display altered AP firing before neighboring excitatory neurons in prodromal AD. Here we report a novel mechanism responsible for PV hypoexcitability in young adult familial AD mice. We found that biophysical modulation of Kv3 channels, but not changes in their mRNA or protein expression, were responsible for dampened excitability in young 5xFAD mice. These K+ conductances could efficiently regulate near-threshold AP firing, resulting in gamma-frequency specific network hyperexcitability. Thus biophysical ion channel alterations alone may reshape cortical network activity prior to changes in their expression levels. Our findings demonstrate an opportunity to design a novel class of targeted therapies to ameliorate cortical circuit hyperexcitability in early AD.

Data availability

We share access to our original code for simulations (single cell, reduced single cell in network, and layer 5 cortical network used in this manuscript for reviewers and the public here: https://github.com/ViktorJOlah/KDR-in-FS-PV. This code dataset has been made publicly available here: https://doi.org/10.5061/dryad.08kprr557For Mass Spec data, full source data has been provided for Supplementary Figure 4 (Related to Main figure 4).

The following data sets were generated

Article and author information

Author details

  1. Viktor J Olah

    Department of Cell Biology, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2069-7525
  2. Annie M Goettemoeller

    Department of Cell Biology, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Sruti Rayaprolu

    Department of Neurology, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Eric B Dammer

    Department of Biochemistry, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Nicholas T Seyfried

    Department of Biochemistry, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Srikant Rangaraju

    Department of Neurology, Emory University, Atlanta, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Jordane Dimidschstein

    Stanley Center for Psychiatric Research, Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Matthew JM Rowan

    Department of Cell Biology, Emory University, Atlanta, United States
    For correspondence
    mjrowan@emory.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0955-0706

Funding

National Institutes of Health (R56AG072473)

  • Matthew JM Rowan

National Institutes of Health (RF1AG062181)

  • Nicholas T Seyfried

National Institutes of Health (F32AG064862)

  • Sruti Rayaprolu

National Institutes of Health (R01MH111529)

  • Jordane Dimidschstein

National Institutes of Health (UG3MH120096)

  • Jordane Dimidschstein

Alzheimer's Disease Research Center, Emory University (00100569)

  • Matthew JM Rowan

National Institutes of Health (R01NS114130)

  • Srikant Rangaraju

National Institutes of Health (R01AG075820)

  • Srikant Rangaraju

National Institutes of Health (RF1AG071587)

  • Srikant Rangaraju

National Institutes of Health (RF1AG071587)

  • Nicholas T Seyfried

National Institutes of Health (R01AG061800)

  • Nicholas T Seyfried

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved Emory University institutional animal care and use committee (IACUC) protocols (#201800199). Every effort was made to reduce animal useage and to minimize suffering.

Reviewing Editor

  1. Inna Slutsky, Tel Aviv University, Israel

Publication history

  1. Preprint posted: October 26, 2021 (view preprint)
  2. Received: November 5, 2021
  3. Accepted: May 19, 2022
  4. Accepted Manuscript published: June 21, 2022 (version 1)
  5. Version of Record published: July 13, 2022 (version 2)

Copyright

© 2022, Olah et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,186
    Page views
  • 371
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Viktor J Olah
  2. Annie M Goettemoeller
  3. Sruti Rayaprolu
  4. Eric B Dammer
  5. Nicholas T Seyfried
  6. Srikant Rangaraju
  7. Jordane Dimidschstein
  8. Matthew JM Rowan
(2022)
Biophysical Kv3 channel alterations dampen excitability of cortical PV interneurons and contribute to network hyperexcitability in early Alzheimer's
eLife 11:e75316.
https://doi.org/10.7554/eLife.75316

Further reading

    1. Genetics and Genomics
    2. Neuroscience
    Carolyn Elya, Danylo Lavrentovich ... Benjamin de Bivort
    Research Article Updated

    For at least two centuries, scientists have been enthralled by the “zombie” behaviors induced by mind-controlling parasites. Despite this interest, the mechanistic bases of these uncanny processes have remained mostly a mystery. Here, we leverage the Entomophthora muscae-Drosophila melanogaster “zombie fly” system to reveal the mechanistic underpinnings of summit disease, a manipulated behavior evoked by many fungal parasites. Using a high-throughput approach to measure summiting, we discovered that summiting behavior is characterized by a burst of locomotion and requires the host circadian and neurosecretory systems, specifically DN1p circadian neurons, pars intercerebralis to corpora allata projecting (PI-CA) neurons and corpora allata (CA), the latter being solely responsible for juvenile hormone (JH) synthesis and release. Using a machine learning classifier to identify summiting animals in real time, we observed that PI-CA neurons and CA appeared intact in summiting animals, despite invasion of adjacent regions of the “zombie fly” brain by E. muscae cells and extensive host tissue damage in the body cavity. The blood-brain barrier of flies late in their infection was significantly permeabilized, suggesting that factors in the hemolymph may have greater access to the central nervous system during summiting. Metabolomic analysis of hemolymph from summiting flies revealed differential abundance of several compounds compared to non-summiting flies. Transfusing the hemolymph of summiting flies into non-summiting recipients induced a burst of locomotion, demonstrating that factor(s) in the hemolymph likely cause summiting behavior. Altogether, our work reveals a neuro-mechanistic model for summiting wherein fungal cells perturb the fly’s hemolymph, activating a neurohormonal pathway linking clock neurons to juvenile hormone production in the CA, ultimately inducing locomotor activity in their host.

    1. Neuroscience
    Flavia Venetucci Gouveia, Jurgen Germann ... Clement Hamani
    Research Article Updated

    Deep brain stimulation targeting the posterior hypothalamus (pHyp-DBS) is being investigated as a treatment for refractory aggressive behavior, but its mechanisms of action remain elusive. We conducted an integrated imaging analysis of a large multi-centre dataset, incorporating volume of activated tissue modeling, probabilistic mapping, normative connectomics, and atlas-derived transcriptomics. Ninety-one percent of the patients responded positively to treatment, with a more striking improvement recorded in the pediatric population. Probabilistic mapping revealed an optimized surgical target within the posterior-inferior-lateral region of the posterior hypothalamic area. Normative connectomic analyses identified fiber tracts and functionally connected with brain areas associated with sensorimotor function, emotional regulation, and monoamine production. Functional connectivity between the target, periaqueductal gray and key limbic areas – together with patient age – were highly predictive of treatment outcome. Transcriptomic analysis showed that genes involved in mechanisms of aggressive behavior, neuronal communication, plasticity and neuroinflammation might underlie this functional network.